INSYS Therapeutics

Organisation

Trials

  • NCT03254459

    Phase 2, Completed, 100 people, 18 Aug 2017

  • NCT02751359

    Collaborator, Phase 1/2, Completed, 18 people, 26 Apr 2016

  • NCT02551731

    Phase 2, Terminated, 9 people, 16 Sept 2015

  • NCT02324673

    Phase 1/2, Completed, 61 people, 24 Dec 2014

  • NCT02318602

    Phase 3, Completed, 52 people, 17 Dec 2014

  • NCT02318563

    Phase 3, Withdrawn, 0 people, 17 Dec 2014

  • NCT02318537

    Phase 3, Withdrawn, 0 people, 17 Dec 2014

  • NCT02137525

    Phase 2, Withdrawn, 0 people, 14 May 2014